ALDONDIS Trademark

Trademark Overview

On Friday, December 14, 2018, a trademark application was filed for ALDONDIS with the United States Patent and Trademark Office. The USPTO has given the ALDONDIS trademark a serial number of 88230501. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 29, 2022. This trademark is owned by PTC THERAPEUTICS, INC.. The ALDONDIS trademark is filed in the Pharmaceutical Products category with the following description:

hormonal compound for medicinal and pharmaceutical use
aldondis

General Information

Serial Number88230501
Word MarkALDONDIS
Filing DateFriday, December 14, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 29, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 28, 2019

Trademark Statements

Goods and Serviceshormonal compound for medicinal and pharmaceutical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 7, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePTC THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSOUTH PLAINFIELD, NJ 07080
Party NamePTC THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSOUTH PLAINFIELD, NJ 07080

Trademark Events

Event DateEvent Description
Monday, August 29, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 29, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 26, 2022SOU EXTENSION 5 GRANTED
Tuesday, January 18, 2022SOU EXTENSION 5 FILED
Wednesday, January 26, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 18, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 20, 2021SOU EXTENSION 4 GRANTED
Tuesday, July 20, 2021SOU EXTENSION 4 FILED
Tuesday, July 20, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, January 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 8, 2021SOU EXTENSION 3 GRANTED
Friday, January 8, 2021SOU EXTENSION 3 FILED
Friday, January 8, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, July 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 20, 2020SOU EXTENSION 2 GRANTED
Monday, July 20, 2020SOU EXTENSION 2 FILED
Monday, July 20, 2020SOU TEAS EXTENSION RECEIVED
Friday, December 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 18, 2019SOU EXTENSION 1 GRANTED
Wednesday, December 18, 2019SOU EXTENSION 1 FILED
Wednesday, December 18, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, July 23, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 28, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 28, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 8, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 24, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 23, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 19, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 19, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 17, 2019ASSIGNED TO LIE
Wednesday, April 10, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 13, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 13, 2019NON-FINAL ACTION E-MAILED
Wednesday, March 13, 2019NON-FINAL ACTION WRITTEN
Tuesday, March 12, 2019ASSIGNED TO EXAMINER
Monday, January 7, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 18, 2018NEW APPLICATION ENTERED

Related Keywords

aldondis pharmaceutical medicinal compound hormonal